Analysed DARE BIOSCIENCE INC (DARE:NASDAQ) News Sources
Dare Bioscience Inc (DARE) (Q2 2026) Earnings Call Highlights: Commercial Launch Milestones and ...
17-08-2026
yahoo.com
Daré Bioscience CEO Outlines Commercial Transformation, Pipeline Momentum and Potential Key Catalysts in Virtual Investor CEO Connect Segment
25-08-2026
yahoo.com
Daré Bioscience CEO, Sabrina Martucci Johnson, Participates in the Virtual Investor “Why Now” On-Demand Series
27-08-2026
yahoo.com
Daré Bioscience Announces New NIH Funding Award for Approximately $908,000 to Advance DARE-PTB2 for the Prevention of Preterm Birth
31-08-2026
yahoo.com
Daré Bioscience Presentation for H.C. Wainwright 28th Annual Global Investment Conference Now Available On-Demand
11-09-2026
yahoo.com
Daré Bioscience to Present Phase 1 Sildenafil Cream Data at Sexual Medicine Society of North America (SMSNA) Annual Fall Scientific Meeting
08-10-2026
yahoo.com
Daré Bioscience Launches “CEO Corner” Video Series to Highlight the Company’s Pipeline of Women’s Health Innovations, Corporate Strategy and Opportunities
13-10-2026
yahoo.com
Daré Bioscience Sponsors HERmedicine Educational Program for Clinicians on Managing Menopause After Breast Cancer
19-10-2026
yahoo.com
What is the current price of DARE BIOSCIENCE INC (DARE:NASDAQ)?
The current price of DARE BIOSCIENCE INC (DARE:NASDAQ) is $0.6438.
DARE BIOSCIENCE INC (DARE:NASDAQ) absolute price change since previous trading day?
The absolute price change of DARE BIOSCIENCE INC (DARE:NASDAQ) since the previous trading day is $-0.0021.
DARE BIOSCIENCE INC (DARE:NASDAQ) percentage price change since previous trading day?
The percentage price change of DARE BIOSCIENCE INC (DARE:NASDAQ) since the previous trading day is -0.3251%.
What is the most recent average sentiment score for DARE BIOSCIENCE INC (DARE:NASDAQ)?
The most recent average sentiment score for DARE BIOSCIENCE INC (DARE:NASDAQ) is 85 out of 100.
What is the most recent average sentiment for DARE BIOSCIENCE INC (DARE:NASDAQ)?
The most recent sentiment for DARE BIOSCIENCE INC (DARE:NASDAQ) is .
SEC-8K** Filing Available For DARE BIOSCIENCE INC (DARE:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.